Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
This is a study for newly-diagnosed breast cancer patients with BRCA mutations. The study is evaluating whether the chemotherapy drug cisplatin is better than currently used standard chemotherapy drugs (Cyclophosphamide/Doxorubicin) for treating patients.
Treatment for Triple-Negative Breast Cancer
2010 FORCE webinar presented by Dr. Melinda Telli of Stanford, providing updates on research specific to triple-negative breast cancer.
Results from TNT Study looking at platinum for Triple-Negative Breast Cancer
Medscape interview with Dr. Andrew Tutt, researcher for the TNT Study which showed that people with BRCA mutations and triple negative breast cancer respond better to platinum chemotherapy than people without mutations.
Store My Tumor
StoreMyTumor is a company that offers tumor banking services. You can decide before surgery to preserve your tumor tissue to enable participation in breakthrough, personalized treatments including immunotherapy.